New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring ...(Masimo Corporation (949) 297-7348 ...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology
Date:10/21/2009
Masimo Corporation (949) 297-7348 dbanks@masimo.com
Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications, Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Radical-7, Rad-87, Rad-57, Rad-9, Rad-8, Rad-5, Pulse CO-Oximetry and Pulse CO-Oximeter are trademarks or registered trademarks of Masimo Corporation.
SOURCE Masimo Corporation
'/>"/>
| SOURCE Masimo Corporation Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
(Date:11/20/2009)...PRNewswire-FirstCall/ -- Escalon Medical Corp. (Na...iscal first quarter ended September 30, 2009. ,...revenue decreased approximately $234,000, or 2.7%,... September 30, 2009 as compared to the same period...ased net revenue of $8,434,000 compared with $8,66...
(Date:11/20/2009)... Unilens Vision Inc. (OTC..., which develops, licenses, manufactures, distribu...ported its operating results for the first quarter...s excluding royalty income, were $1,683,673 in the...eported in the previous year first quarter (FY2009...
(Date:11/20/2009)...ov. 20 The National Association of...ced a new initiative in the war on methamphetamine...a multi-state electronic tracking program that enf...C) medicines containing pseudoephedrine in real-ti... is based on a system that was developed and teste...
Breaking Medicine Technology:Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3Journal of Midwifery 26amp 3B Womens Health honors outstanding authors 54619 1Journal of Midwifery 26amp 3B Womens Health honors outstanding authors 54619 2Imagenetix Inc Announces Interview With Bloomberg Radio 13589 1Imagenetix Inc Announces Interview With Bloomberg Radio 13589 2Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 1Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 2Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 3Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 4...gentina, May 21 Today at the,World Congress of Ca...,Perspectives in Atrial Fibrillation Management" c...gy, St George,s University of London,highlighted t...al trial,results, as the way forward in the future...n form of cardiac arrhythmia., To view the Multim...
...gnificant Reduction of IBS Pain and Normalizing Mo... SAN DIEGO, May 20 Tioga Pharmaceuticals, Inc. t...udy of its oral kappa opioid,receptor agonist, asi...cant,results in the treatment of Irritable Bowel S...provement in diarrhea-predominant (D-IBS) and,alte...
Other Medicine Technology:ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 2ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 3ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 4ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 5ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 6Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 2Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 3Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 4(Date:11/21/2009)...N, Nov. 21 A regional i...cerciasis (river blindness) in the Americas has su...in recent years, as evidenced by a 31% decrease in...inistration in six endemic countries. Results wer... American Society of Tropical Medicine and Hygiene...
(Date:11/21/2009)... NH based medical credentialing software compan...o form a partnerhsip with Amerinet, Inc., the lead...p will help to transform quality care within the h...s) November 21, 2009 -- ISG Group, LLC, doing busi...eement with Amerinet Inc., a leading national heal...
(Date:11/21/2009)... Eric J. Hall, president and chief executive of...A) issued the following statement regarding the in...of the new annual wellness for Medicare beneficiar... Care Act" that was introduced last night: ,...mber 21, 2009 -- Eric J. Hall, president and chief...
(Date:11/20/2009)...Neurologist Closer to Understanding Brain Wiring a...USNewswire/ -- Dr. Jeremy Schmahmann, Professor of...st at the Massachusetts General Hospital in Boston...ry,s research on the new field of study called "Co...on. ,, Dr. Schmahmann is an award-winning leade...
(Date:11/20/2009)...GTON, Nov. 20 The Unite...Senate to make essential changes its health reform...rtion funding and conscience protection on abortio...d include strong provisions for adequate affordabi...are bill an "enormous disappointment" that creates...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2[0] River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries[0] IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care[0] Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform [0] MINDlink Foundation Launches to Connect the Cerebellum to Cures[0] U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability
...ion with its obsession of MP3 players that blare o...of going deaf than the previous generation.// Rese... 14 to 16 year olds use their MP3 players for a mi...stening to loud music. 28 percent of those polled ...
...ty Executive (HSE) says that recycling boxes are u...o lift them. In a new report, the HSE// said that .... The containers, which are used by countless hous...t. The report, which was compiled after a three-mo...
...vestigations conducted by the General of Health De...d positive for containing harmful drugs in erectil...ines.
After routine investigations Medsafe ide...uld also interfere with some heart medications. ...
...leases a dose of nicotine and is one of the import...king.//
The federal government has announced t.... The lozenges are to join nicotine patches, gums ...rict the availability of a safe and effective smok...
...ate has risen since the government sang from the "...song sheet and began paying out 3,000 Australian//... released Monday showed.
But Treasurer Peter...ity rate that is the bane of Australia - and most ...
...ting programme for notifiable avian influenza has ...meat industry is free of the disease according// t...Michael Brooks.
The testing programme has tes...s from thousands of poultry meat birds.
There...
Other Medicine News:Health News:Australia's Baby Bonus Plan has Increased the Birth Rate 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |